Emm

Emm, founded in 2020, is innovating within the Biotechnology sector by spearheading the development of the next generation of bio-wearables aimed at enhancing healthcare outcomes. With a strong focus on integrating advanced technology into everyday devices, Emm positions itself uniquely at the intersection of health and wearable tech, promising a new wave of consumer-centric health monitoring products.

Headquartered in the United Kingdom, Emm leverages cutting-edge research and development to address a growing demand for personalized medical solutions. The strategic endeavor gained momentum following its Seed Round investment on 31 October 2023, when Alumni Ventures became a primary backer, endorsing its potential in reshaping the landscape of bio-wearable technology.

For investors, Emm represents a promising opportunity to become a part of an evolving market driven by technological breakthroughs and the escalating need for innovative healthcare solutions.